Offer - Urjas Oil for just ₹ 1 X
Kemocarb 450 Injection is a prescription medicine that is available as a Injection. It is primarily used for the treatment of Ovarian Cancer. Other than this, Kemocarb 450 Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Kemocarb 450 Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Kemocarb 450 Injection as well, which are listed below. Usually, these side effects of Kemocarb 450 Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Kemocarb 450 Injection's effect during pregnancy is Severe and Severe while nursing. In addition, Kemocarb 450 Injection's effects on the liver, heart and kidney are discussed below in the Kemocarb 450 Injection related warnings section.
Kemocarb 450 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Kemocarb 450 Injection in conditions like Anemia, Neutropenia, Infections. The section on Kemocarb 450 Injection contraindications lists all such conditions.
Additionally, Kemocarb 450 Injection may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Kemocarb 450 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Kemocarb 450 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Kemocarb 450 Injection safe for pregnant women?
Kemocarb has many dangerous side effects in pregnant women. If you are pregnant, do not consume Kemocarb without medical advice.
Is the use of Kemocarb 450 Injection safe during breastfeeding?
Taking Kemocarb may lead to serious side effects if you are breastfeeding. Kemocarb should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Kemocarb 450 Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Kemocarb. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Kemocarb 450 Injection on the Liver?
Kemocarb is completely safe for the liver.
What is the effect of Kemocarb 450 Injection on the Heart?
Kemocarb is completely safe for the heart.
Kemocarb 450 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Kemocarb 450 Injection unless your doctor advises you to do so -
Is this Kemocarb 450 Injection habit forming or addictive?
No, you will not get addicted to Kemocarb 450 Injection.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Kemocarb 450 Injection can make you feel drowsy.
Is it safe?
Kemocarb 450 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Kemocarb 450 Injection in mental disorders is not effective.
Interaction between Food and Kemocarb 450 Injection
Taking Kemocarb 450 Injection with food is safe.
Interaction between Alcohol and Kemocarb 450 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Kemocarb 450 Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 282-283
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Paraplatin® (carboplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Carboplatin Accord(carboplatin)